Research Article
Clinical Outcomes and Adverse Events of Endoscopic Submucosal Dissection for Gastric Tube Cancer after Esophagectomy
Table 3
Noncurative resection cases.
| Case | Age | Location | Procedure in retroflex position | Interval between esophagectomy and ESD (month) | Reason for noncurative resection | Additional treatment | Follow-up duration (months) | Recurrence | Vital status | Cause of death in fatal cases |
| 1 | 73 | Middle | Unnecessary | 88 | HM+ | Follow-up | 25 | None | Dead | Infectious pneumonia | 2 | 72 | Lower | Unnecessary | 264 | HM+ | Follow-up | 33 | None | Dead | Colon cancer | 3 | 70 | Middle | Necessary | 113 | SM2, VM+, Ly+, V+ | Follow-up | 28 | Local recurrence | Dead | Interstitial pneumonia | 4 | 75 | Middle | Necessary | 60 | SM2, HM+, VM+, Ly+ | Surgical resection | 58 | None | Alive | — |
|
|
ESD: endoscopic submucosal dissection. Reasons for noncurative resection: HM+: horizontal margin positive; SM2: invasive submucosal cancer, invasion depth ≥ 500 μM from the muscularis; VM+: vertical margin positive; Ly+: lymphatic invasion positive; V+: vascular invasion positive.
|